Vaccinology in the Age of Pandemics:
Strategies Against COVID-19 & Other Global Threats
June 15–16, 2020 | 11:00AM–3:30PM ET | 3:00–7:30PM UTC | 5:00–9:30PM CEST*
*Program is subject to change
Attention
The live portion of this conference has concluded and all presentations are now available for purchase on demand. Registrants to the live event may access this content anytime for up to 9 months following the event.
Free Access to On Demand Content to Scientists from Low-and Middle-Income Countries
Keystone Symposia welcomes the global scientific community and aims to connect researchers within and across disciplines to accelerate the advancement of biomedical and life sciences. This form may be used for scientists from low- and middle-income countries of all career stages to determine eligibility and request free access to scientific content presented during recent eSymposia events. If eligible, you will be sent an access code for the On Demand content of the eSymposia event(s) of interest.
As the world faces the greatest global pandemic of our lifetimes, the critical importance of vaccine development has come to the forefront of scientific and public audiences alike. Over the course of history, vaccination has enabled us to conquer devastating diseases from measles to smallpox, but new challenges arise when addressing an emerging pandemic in real time. This virtual meeting will assemble the world’s leading vaccinology and global health experts to present the latest advances in vaccine design and development. Finally, this virtual conference will discuss how to best apply these strategies in the context of the current pandemic.
The field of vaccinology has made great leaps in recent years, providing novel technologies and approaches that can be leveraged to our advantage against the novel coronavirus, COVID-19. Incredible advances in science and technology now make it technically possible to develop vaccines against many new targets. Meanwhile, innovative approaches to vaccine development are tackling challenges of emerging infections and implementation in low-income countries. These advances, among many others, will guide the way towards a safe and effective COVID-19 vaccine. Additionally, these new scientific advances will set the stage for success against this pandemic, as vaccinologists race against the ever-rising global death toll.
This virtual meeting program will cover many important facets of vaccine science, technology and strategy, including:
- transformative new technologies, including structure-based design, adjuvants, nucleic acid vaccines (especially RNA), viral vectors, systems biology, and controlled human infections
- scientific underpinnings of new vaccinology strategies, including advances in the fields of human immunology, genomics, synthetic biology, molecular structure of antigens and antigen-antibody complexes, germinal centers, and microbiome
- multidisciplinary technologies and strategies, including efforts of Coalition for Epidemic Preparedness Innovations (CEPI), Bill & Melinda Gates Foundation and Wellcome Trust, which will change the way vaccines are developed
Program is intended for scientific researchers and clinical audiences.
Join us for this landmark virtual event, brought to you by Keystone Symposia.
Registration is now closed for this event. Please join us for an upcoming eSymposia.
#VKSvaxcovid19
Keynote Speaker
Anthony S. Fauci, MD
NIAID, National Institutes of Health
Transforming Vaccinology: Considerations for the Next Decade
Speaking at this eSymposia
Galit Alter
MIT and Harvard University
Yasmine Belkaid
NIAID, National Institutes of Health
Anthony S. Fauci
NIAID, National Institutes of Health
George Fu Gao
Chinese Academy of Sciences
Barney S. Graham
NIAID, National Institutes of Health
Richard Hatchett
Coalition for Epidemic Preparedness Innovations, CEPI
Neil P. King
University of Washington
Antonio Lanzavecchia
Institute for Research in Biomedicine
Ulrike Protzer
Technische Universität München
Bali Pulendran
Stanford University School of Medicine
Rino Rappuoli
GlaxoSmithKline Vaccines
Federica Sallusto
Università della Svizzera Italiana & ETH Zurich
Robert A. Seder
NIAID, National Institutes of Health
Robin Shattock
Imperial College London
Lynda M. Stuart
Bill & Melinda Gates Foundation
Christine Shaw
Moderna
Gabriel D. Victora
Rockefeller University
Hedda Wardemann
German Cancer Research Center
Catherine J. Wu
Dana-Farber Cancer Institute
Editors Attending This Meeting
Teodoro-Pulvirenti, PhD
Executive Editor, Journal of Experimental Medicine (JEM)
Gaia Trincucci, PhD
Scientific Editor, Journal of Experimental Medicine (JEM)
Céline Carret, PhD
Scientific Editor, EMBO Molecular Medicine
Zeljko Durdevic, PhD
Scientific Editor, EMBO Molecular Medicine
Denise Doolan, PhD
Specialty Chief Editor, Frontiers in Immunology
Alessandra Fornarelli, Dr. rer. nat.
Journal Manager, Frontiers in Immunology
The views expressed in this eSymposia are those of the participants and not necessarily of the participants’ organizations or of Keystone Symposia.
Related Keystone Symposia In-Person Meetings
This new virtual meeting format came out of difficult circumstances, but your commitment to scientific progress is what inspired us to launch Keystone eSymposia. In these virtual meetings, we are capturing the same innovative essence of our in-person meetings that you've all created as a scientific community. Here, Debbie Johnson, our CEO, explains how we're going to do that.
